Kohe S, Brundler MA, Jenkinson H, Parulekar M, Wilson M, Peet AC, McConville CM, Metabolite profiling in retinoblastoma identifies novel clinicopathological subgroups. Br J Cancer, 2015. 113: 1216-24.
Mussai F, Egan S, Hunter S, Webber H, Fisher J, Wheat R, McConville C, Sbirkov Y, Wheeler K, Bendle G, Petrie K, Anderson J, Chesler L, De Santo C, Neuroblastoma Arginase Activity Creates an Immunosuppressive Microenvironment That Impairs Autologous and Engineered Immunity. Cancer Res, 2015. 75: 3043-53.
Pan X, Wilson M, McConville C, Arvanitis TN, Griffin JL, Kauppinen RA, Peet AC, Increased unsaturation of lipids in cytoplasmic lipid droplets in DAOY cancer cells in response to cisplatin treatment. Metabolomics, 2013. 9: 722-9.
Kapatai G, Brundler MA, Jenkinson H, Kearns P, Parulekar M, Peet AC, McConville CM, Gene expression profiling identifies different sub-types of retinoblastoma. Br J Cancer, 2013. 109: 512-25.
Pan X, Wilson M, McConville C, Brundler MA, Arvanitis TN, Shockcor JP, Griffin JL, Kauppinen RA, Peet AC, The lipid composition of isolated cytoplasmic lipid droplets from a human cancer cell line, BE(2)M17. Mol Biosyst, 2012. 8: 1694-700.
Pan X, Wilson M, McConville C, Arvanitis TN, Kauppinen RA, Peet AC, The size of cytoplasmic lipid droplets varies between tumour cell lines of the nervous system: a (1)H NMR spectroscopy study. MAGMA, 2012. 25:479-485.
Mirbahai L, Wilson M, Shaw CS, McConville C, Malcomson RD, Kauppinen RA, Peet AC, Lipid biomarkers of glioma cell growth arrest and cell death detected by (1) H magic angle spinning MRS. NMR Biomed, 2012. 25:1253-1262.
Pan X, Wilson M, Mirbahai L, McConville C, Arvanitis TN, Griffin JL, Kauppinen RA, Peet AC, In vitro metabonomic study detects increases in UDP-GlcNAc and UDP-GalNAc, as early phase markers of cisplatin treatment response in brain tumor cells. J Proteome Res, 2011. 10: 3493-500.
Mirbahai L, Wilson M, Shaw CS, McConville C, Malcomson RD, Griffin JL, et al. (1)H magnetic resonance spectroscopy metabolites as biomarkers for cell cycle arrest and cell death in rat glioma cells. Int J Biochem Cell Biol. 2011. 43:990-1001.
Abbaszadeh F, Barker K, McConville C, Scott R, Rahman N. A new familial cancer syndrome including predisposition to Wilms tumor and neuroblastoma. Familial Cancer. 2010;9(3):425-30.
Wilson M, Davies N, Brundler M-A, McConville C, Grundy R, Peet A. High resolution magic angle spinning 1H-NMR of childhood brain and nervous system tumours. Molec Cancer. 2009;8:6:doi:10.1186/476-4598-8-6.
Capasso M, Devoto M, Hou C, Asgharzadeh S, Glessner J, Attiyeh E, et al. Common variations in BARD1 influence susceptibility to high-risk neuroblastoma. Nature Genetics. 2009;41:718-23.
Marston E, Weston V, Jesson J, Maina E, McConville C, Agathanggelou A, et al. Stratification of paediatric ALL by in vitro cellular responses to DNA double strand breaks provides insight into the molecular mechnanisms underlying clinical response. Blood. 2008;113:117-26.
Maris J, Mosse Y, Bradfield J, Hou C, Monni S, Scott R, et al. Chromosome 6p22 locus associated with clinically aggressive neuroblastoma. New Eng J Med. 2008;358:2585-93.
Peet A, McConville C, Wilson M, Levine B, Reed M, Dyer S, et al. 1H Magnetic resonance spectroscopy identifies specific metabolite profiles associated with MYCN amplified and non-amplified tumour subtypes of neuroblastoma cell lines. NMR in Biomedicine. 2007;20:692-700.
McConville C, Reid S, Baskcomb L, Douglas J, Rahman N. PHOX2B analysis in non-syndromic neuroblastoma cases reveals novel mutations. Am J Med Genet. 2006;140A:1297-301.
View all publications in research portal